Details for: PRO-LEVETIRACETAM
Company: PRO DOC LIMITEE
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02311372 | PRO-LEVETIRACETAM - 250 | LEVETIRACETAM | 250 MG | TABLET | ORAL |
| 02311380 | PRO-LEVETIRACETAM - 500 | LEVETIRACETAM | 500 MG | TABLET | ORAL |
| 02311399 | PRO-LEVETIRACETAM - 750 | LEVETIRACETAM | 750 MG | TABLET | ORAL |
Summary Reports
Summary Safety Review - KEPPRA (levetiracetam) - Assessing the Potential Risk of Acute Kidney Injury (Acute renal failure/Interstitial nephritis)
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.